HCP Strategy Lead – Western Europe

Opella; Reading; Hybrid; GBP 50,000 - 66,000; Full time

Job summary

Opella is seeking an HCP Lead Western Europe to translate global strategy into locally relevant priorities and actionable plans across markets. You will lead the execution of the HCP strategy, engaging pharmacists and healthcare professionals through integrated face-to-face and digital experiences with clear success metrics.

This role drives cross‑functional collaboration, governance and investment choices to deliver measurable HCP and business impact, with a LI-HYBRID working model.

Qualifications

• Experience in healthcare marketing, HCP engagement or field force leadership with measurable impact at market level.
• Ability to translate HCP strategy into clear priorities, metrics and actions.
• Experience designing omnichannel HCP engagement across face-to-face and digital channels.
• Inclusive leadership across multiple markets with cross-functional collaboration.
• Fluent English; other Western European language is advantageous.

Responsibilities

• Define and deliver the Western Europe HCP strategy with market plans and measurable impact.
• Embed HCP strategy into brand planning and field execution with KPIs and success metrics.
• Design and optimize mix of face-to-face and digital HCP engagement using insights.
• Partner with medical, brand, commercial, sales and digital teams to deliver aligned experiences.
• Lead the regional HCP team with clear direction and cross-market execution.
• Drive investment, governance and compliance, tracking HCP performance and outcomes.

Skills

Healthcare marketing

HCP engagement

Field leadership

Strategic thinking

Job description

Opella is seeking an HCP Lead Western Europe to translate global strategy into locally relevant priorities and actionable plans across markets. You will lead the execution of the HCP strategy, engaging pharmacists and healthcare professionals through integrated face-to-face and digital experiences with clear success metrics.

This role drives cross‑functional collaboration, governance and investment choices to deliver measurable HCP and business impact, with a LI-HYBRID working model.